Cargando…
Transforming Growth Factor-β1: A Novel Cause of Resistance to Bronchodilators in Asthma?
Autores principales: | Wortley, Michael A., Bonvini, Sara J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670036/ https://www.ncbi.nlm.nih.gov/pubmed/30768914 http://dx.doi.org/10.1165/rcmb.2019-0020ED |
Ejemplares similares
-
Bronchodilator responsiveness or reversibility in asthma and COPD – a need for clarity
por: Barjaktarevic, Igor, et al.
Publicado: (2018) -
Anxiolytics for Bronchodilation: Refinements to GABA(A) Agonists for Asthma Relief
por: Nayak, Ajay P., et al.
Publicado: (2022) -
Latrophilin receptors: novel bronchodilator targets in asthma
por: Faiz, A, et al.
Publicado: (2017) -
Which bronchodilator in COPD?
por: Russell, Richard, et al.
Publicado: (2007) -
Novel airway smooth muscle–mast cell interactions and a role for the TRPV4-ATP axis in non-atopic asthma
por: Bonvini, Sara J., et al.
Publicado: (2020)